Vor Biopharma Inc.
Vor Biopharma Inc. (VOR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VOR · as of Jun 9, 2026
Key Statistics
Explore Vor Biopharma Inc. Data
vor stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 76.9%
The VOR analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $31.67, representing +138.30% upside from the current price of $13.29.
Competitors & Peers
vor competitorsVOR
ACTU
ALEC
ANIX
APLT
FATEStock Performance
Full HistoryAbout Vor Biopharma Inc.
Vor Biopharma Inc. Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product cand…
what is vor biopharma inc. · vor stock overview · vor biopharma inc. company profile · who is vor biopharma inc. ceo · vor NASDAQ · vor biopharma inc. headquarters · vor biopharma inc. business segments
About Stock Overview & Key Data
Vor Biopharma Inc. (VOR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 5, 2021. As of the latest trading session, VOR stock price is $13.29, with a market capitalization of $91.1M. The stock has returned +197.98% over the past 12 months and +1.61% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Vor Biopharma Inc. stock is Buy, with an average 12-month price target of $31.67. In fiscal year 2025, Vor Biopharma Inc. reported revenue of — and net income of -$696.0M. For detailed data — including Vor Biopharma Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Vor Biopharma Inc. (VOR) stock price is $13.29. The stock is traded on NASDAQ under the ticker symbol VOR. The 52-week range is $3.62 – $65.80.